332 related articles for article (PubMed ID: 27250024)
1. Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer.
Moon PG; Lee JE; Cho YE; Lee SJ; Chae YS; Jung JH; Kim IS; Park HY; Baek MC
Oncotarget; 2016 Jun; 7(26):40189-40199. PubMed ID: 27250024
[TBL] [Abstract][Full Text] [Related]
2. Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection.
Moon PG; Lee JE; Cho YE; Lee SJ; Jung JH; Chae YS; Bae HI; Kim YB; Kim IS; Park HY; Baek MC
Clin Cancer Res; 2016 Apr; 22(7):1757-66. PubMed ID: 26603257
[TBL] [Abstract][Full Text] [Related]
3. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles.
Koi Y; Tsutani Y; Nishiyama Y; Ueda D; Ibuki Y; Sasada S; Akita T; Masumoto N; Kadoya T; Yamamoto Y; Takahashi RU; Tanaka J; Okada M; Tahara H
Cancer Sci; 2020 Jun; 111(6):2104-2115. PubMed ID: 32215990
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.
Ozawa PMM; Jucoski TS; Vieira E; Carvalho TM; Malheiros D; Ribeiro EMSF
Transl Res; 2020 Sep; 223():40-60. PubMed ID: 32413499
[TBL] [Abstract][Full Text] [Related]
5. The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer.
Schwich E; Rebmann V
Front Immunol; 2018; 9():584. PubMed ID: 29632535
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer.
Sadovska L; Eglītis J; Linē A
Anticancer Res; 2015 Dec; 35(12):6379-90. PubMed ID: 26637847
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer.
Li G; Sun Y; Huang Y; Lian J; Wu S; Luo D; Gong H
BMC Cancer; 2023 May; 23(1):473. PubMed ID: 37221488
[TBL] [Abstract][Full Text] [Related]
9. Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies.
Li D; Lai W; Fan D; Fang Q
Am J Physiol Cell Physiol; 2021 Nov; 321(5):C779-C797. PubMed ID: 34495763
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
12. Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood.
Notarangelo M; Zucal C; Modelska A; Pesce I; Scarduelli G; Potrich C; Lunelli L; Pederzolli C; Pavan P; la Marca G; Pasini L; Ulivi P; Beltran H; Demichelis F; Provenzani A; Quattrone A; D'Agostino VG
EBioMedicine; 2019 May; 43():114-126. PubMed ID: 31047861
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
Yoshioka Y; Katsuda T; Ochiya T
Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
[TBL] [Abstract][Full Text] [Related]
14. Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.
Chen IH; Xue L; Hsu CC; Paez JS; Pan L; Andaluz H; Wendt MK; Iliuk AB; Zhu JK; Tao WA
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3175-3180. PubMed ID: 28270605
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening.
Ruiz-Garcia E; Scott V; Machavoine C; Bidart JM; Lacroix L; Delaloge S; Andre F
Br J Cancer; 2010 Feb; 102(3):462-8. PubMed ID: 20068563
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicle-Based Multianalyte Liquid Biopsy as a Diagnostic for Cancer.
Lin AA; Nimgaonkar V; Issadore D; Carpenter EL
Annu Rev Biomed Data Sci; 2022 Aug; 5():269-292. PubMed ID: 35562850
[TBL] [Abstract][Full Text] [Related]
17. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
Henderson MC; Hollingsworth AB; Gordon K; Silver M; Mulpuri R; Letsios E; Reese DE
PLoS One; 2016; 11(8):e0157692. PubMed ID: 27508384
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
19. Circulating Cellular Communication Network Factor 1 Protein as a Sensitive Liquid Biopsy Marker for Early Detection of Breast Cancer.
Bartkowiak K; Heidrich I; Kwiatkowski M; Banys-Paluchowski M; Andreas A; Wurlitzer M; Geffken M; Voß H; Zeller T; Blankenberg S; Peine S; Joosse SA; Müller V; Schlüter H; Oliveira-Ferrer L; Pantel K
Clin Chem; 2022 Feb; 68(2):344-353. PubMed ID: 34458901
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles from Thyroid Carcinoma: The New Frontier of Liquid Biopsy.
Rappa G; Puglisi C; Santos MF; Forte S; Memeo L; Lorico A
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
